Clinical Trial Update: Multiple Ascending Dose Study of TC-5619 in Healthy Elderly Subjects and Subjects With Alzheimer's Disease [Phase 1]

View source ↗

Summary

A Phase 1 multiple ascending dose study of TC-5619 in healthy elderly subjects and individuals with Alzheimer's disease has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Alzheimer Disease

Drugs mentioned

• TC-5619

Snippet

Sponsor: Targacept Inc. | Conditions: Alzheimer's Disease | Phase 1 | Status: COMPLETED